Two-Stage Cooperative T Cell Receptor-Peptide Major Histocompatibility Complex-CD8 Trimolecular Interactions Amplify Antigen Discrimination

Immunity

Volumn 34, Issue 1, 2011, Pages 13-23

  Jiang, Ning ^a,c   Huang, Jun ^a,d   Edwards, Lindsay J ^b   Liu, Baoyu ^a   Zhang, Yan ^a,e   Beal, Carrie D ^b,f   Evavold, Brian D ^b   Zhu, Cheng ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Stanford University   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f Mount Vernon Nazarene University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; ENZYME ACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD8; CELLS, CULTURED; FEEDBACK, PHYSIOLOGICAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 78751696945     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.12.017     Document Type: Article

References (53)

1. Alam S.M., Travers P.J., Wung J.L., Nasholds W., Redpath S., Jameson S.C., Gascoigne N.R. T-cell-receptor affinity and thymocyte positive selection. Nature 1996, 381:616-620.
2. Campanelli R., Palermo B., Garbelli S., Mantovani S., Lucchi P., Necker A., Lantelme E., Giachino C. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation. Int. Immunol. 2002, 14:39-44.
3. Campi G., Varma R., Dustin M.L. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 2005, 202:1031-1036.
4. Chesla S.E., Selvaraj P., Zhu C. Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys. J. 1998, 75:1553-1572.
5. Daniels M.A., Jameson S.C. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 2000, 191:335-346.
6. Davis M.M., Krogsgaard M., Huppa J.B., Sumen C., Purbhoo M.A., Irvine D.J., Wu L.C., Ehrlich L. Dynamics of cell surface molecules during T cell recognition. Annu. Rev. Biochem. 2003, 72:717-742.
7. Davis M.M., Krogsgaard M., Huse M., Huppa J., Lillemeier B.F., Li Q.J. T cells as a self-referential, sensory organ. Annu. Rev. Immunol. 2007, 25:681-695.
8. Delon J., Gregoire C., Malissen B., Darche S., Lemaitre F., Kourilsky P., Abastado J.P., Trautmann A. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity 1998, 9:467-473.
9. Devine L., Hodsdon M.E., Daniels M.A., Jameson S.C., Kavathas P.B. Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation. Immunol. Lett. 2004, 93:123-130.
10. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002, 20:55-72.
11. Evavold B.D., Allen P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991, 252:1308-1310.
12. Evavold B.D., Sloan-Lancaster J., Allen P.M. Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 1993, 14:602-609.
13. Ford M.L., Evavold B.D. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55. J. Immunol. 2003, 171:1247-1254.
14. Gakamsky D.M., Luescher I.F., Pramanik A., Kopito R.B., Lemonnier F., Vogel H., Rigler R., Pecht I. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 2005, 89:2121-2133.
15. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., Jakobsen B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 1997, 387:630-634.
16. Gao G.F., Rao Z., Bell J.I. Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. Trends Immunol. 2002, 23:408-413.
17. Garcia K.C., Scott C.A., Brunmark A., Carbone F.R., Peterson P.A., Wilson I.A., Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996, 384:577-581.
18. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 1996, 271:695-701.
19. Holman P.O., Walsh E.R., Jameson S.C. Characterizing the impact of CD8 antibodies on class I MHC multimer binding. J. Immunol. 2005, 174:3986-3991.
20. Huang J., Edwards L.J., Evavold B.D., Zhu C. Kinetics of MHC-CD8 interaction at the T cell membrane. J. Immunol. 2007, 179:7653-7662.
21. Huang J., Zarnitsyna V.I., Liu B., Edwards L.J., Jiang N., Evavold B.D., Zhu C. The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature 2010, 464:932-936.
22. Huppa J.B., Axmann M., Mortelmaier M.A., Lillemeier B.F., Newell E.W., Brameshuber M., Klein L.O., Schutz G.J., Davis M.M. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 2010, 463:963-967.
23. Huse M., Klein L.O., Girvin A.T., Faraj J.M., Li Q.J., Kuhns M.S., Davis M.M. Spatial and temporal dynamics of T cell receptor signaling with a photoactivatable agonist. Immunity 2007, 27:76-88.
24. Irvine D.J., Purbhoo M.A., Krogsgaard M., Davis M.M. Direct observation of ligand recognition by T cells. Nature 2002, 419:845-849.
25. Kane L.P., Weiss A. The PI-3 kinase/Akt pathway and T cell activation: Pleiotropic pathways downstream of PIP3. Immunol. Rev. 2003, 192:7-20.
26. Kern P.S., Teng M.K., Smolyar A., Liu J.H., Liu J., Hussey R.E., Spoerl R., Chang H.C., Reinherz E.L., Wang J.H. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb. Immunity 1998, 9:519-530.
27. Kerry S.E., Buslepp J., Cramer L.A., Maile R., Hensley L.L., Nielsen A.I., Kavathas P., Vilen B.J., Collins E.J., Frelinger J.A. Interplay between TCR affinity and necessity of coreceptor ligation: High-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. J. Immunol. 2003, 171:4493-4503.
28. Kim S.T., Takeuchi K., Sun Z.Y., Touma M., Castro C.E., Fahmy A., Lang M.J., Wagner G., Reinherz E.L. The alphabeta T cell receptor is an anisotropic mechanosensor. J. Biol. Chem. 2009, 284:31028-31037.
29. Laugel B., van den Berg H.A., Gostick E., Cole D.K., Wooldridge L., Boulter J., Milicic A., Price D.A., Sewell A.K. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 2007, 282:23799-23810.
30. Li Y.C., Chen B.M., Wu P.C., Cheng T.L., Kao L.S., Tao M.H., Lieber A., Roffler S.R. Cutting edge: Mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signaling. J. Immunol. 2010, 184:5959-5963.
31. Luescher I.F., Vivier E., Layer A., Mahiou J., Godeau F., Malissen B., Romero P. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 1995, 373:353-356.
32. Norment A.M., Salter R.D., Parham P., Engelhard V.H., Littman D.R. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988, 336:79-81.
33. Palacios E.H., Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004, 23:7990-8000.
34. Pecht I., Gakamsky D.M. Spatial coordination of CD8 and TCR molecules controls antigen recognition by CD8+ T-cells. FEBS Lett. 2005, 579:3336-3341.
35. Purbhoo M.A., Irvine D.J., Huppa J.B., Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 2004, 5:524-530.
36. Rudolph M.G., Stanfield R.L., Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 2006, 24:419-466.
37. Sabatino J.J., Shires J., Altman J.D., Ford M.L., Evavold B.D. Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. J. Immunol. 2008, 180:4451-4457.
38. Smyth L.A., Ardouin L., Williams O., Norton T., Tybulewicz V., Kioussis D. Inefficient clustering of tyrosine-phosphorylated proteins at the immunological synapse in response to an antagonist peptide. Eur. J. Immunol. 2002, 32:3386-3394.
39. Thome M., Duplay P., Guttinger M., Acuto O. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex. J. Exp. Med. 1995, 181:1997-2006.
40. Thome M., Germain V., DiSanto J.P., Acuto O. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex. Eur. J. Immunol. 1996, 26:2093-2100.
41. Tomonari K., Spencer S. Epitope-specific binding of CD8 regulates activation of T cells and induction of cytotoxicity. Int. Immunol. 1990, 2:1189-1194.
42. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell 1994, 76:263-274.
43. Wooldridge L., Hutchinson S.L., Choi E.M., Lissina A., Jones E., Mirza F., Dunbar P.R., Price D.A., Cerundolo V., Sewell A.K. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: This is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J. Immunol. 2003, 171:6650-6660.
44. Wulfing C., Rabinowitz J.D., Beeson C., Sjaastad M.D., McConnell H.M., Davis M.M. Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 1997, 185:1815-1825.
45. Wyer J.R., Willcox B.E., Gao G.F., Gerth U.C., Davis S.J., Bell J.I., van der Merwe P.A., Jakobsen B.K. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity 1999, 10:219-225.
46. Xu H., Littman D.R. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell 1993, 74:633-643.
47. Xu X.N., Purbhoo M.A., Chen N., Mongkolsapaya J., Cox J.H., Meier U.C., Tafuro S., Dunbar P.R., Sewell A.K., Hourigan C.S., et al. A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. Immunity 2001, 14:591-602.
48. Xu C., Gagnon E., Call M.E., Schnell J.R., Schwieters C.D., Carman C.V., Chou J.J., Wucherpfennig K.W. Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Cell 2008, 135:702-713.
49. Yachi P.P., Ampudia J., Zal T., Gascoigne N.R. Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality. Immunity 2006, 25:203-211.
50. Yokosuka T., Sakata-Sogawa K., Kobayashi W., Hiroshima M., Hashimoto-Tane A., Tokunaga M., Dustin M.L., Saito T. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat. Immunol. 2005, 6:1253-1262.
51. Zamoyska R. Why is there so much CD45 on T cells?. Immunity 2007, 27:421-423.
52. Zhu C., Williams T.E. Modeling concurrent binding of multiple molecular species in cell adhesion. Biophys. J. 2000, 79:1850-1857.
53. Zhu C., Long M., Chesla S.E., Bongrand P. Measuring receptor/ligand interaction at the single-bond level: Experimental and interpretative issues. Ann. Biomed. Eng. 2002, 30:305-314.